The parliamentary Health Committee almost unanimously adopted a bill facilitating the creation of a cannabis agency, enabling production of the drug for medical purposes.
Cannabis will now be able to be prescribed for patients for whom mainstream medicines have proven to be of little or no use. Such a prescription will be done through the creation of a specific agency.
Increasingly countries are allowing the use of cannabis for therapeutic ends. The drug in particular provides relief from illnesses such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, or for those suffering from pains or spasms.
The cannabis agency would work under the auspices of …

The European Parliament is calling for an EU-wide policy for medical cannabis and properly funded scientific research.
Several EU countries have legalised the medical use of some form of cannabis or …

MEPs will debate ways to address research gaps on medical cannabis with the European Commission, and adopt a resolution on Wednesday.
MEPs will quiz the Commission on how the EU could …

The three parties in Belgium’s outgoing government have come up with a bill seeking to establish a government agency to control the production of cannabis for therapeutic use.
The draft law …

The Rendocan team has visited the highly anticipated Cannabis Europa conference in Paris, France.
“There is obviously a paradigm shift going on in Europe as more and more countries are allowing …

The operational team of Rendocan participated in a masterclass on supercritical CO2 extraction, hosted by the UCLL in Leuven.
Supercritical CO2 is a fluid state in which carbon dioxide has the …

Rendocan is pleased to enter into a partnership with VITO (Flemish Institute for Technological Development). Through the partnership, both companies will develop new technologies in cannabis analytics, extraction, medical devices …